Duc Tran has joined ArisGen as Preclinical & PhI...
NEWS & EVENTS
Campus Biotech - Geneva,...
Say Hello to Paolo Botti in Zermatt
Paolo Botti (...
The 2014 BIO International Convention is June 23-26 at...
Say Hello to Paolo Botti in Naples.
Dr Paolo Botti...
Andrew Parker, CEO and Paolo Botti, CSO will be...
Say Hello to Paolo Botti in Tokyo
Dr Paolo Botti (...
Arisgen is a drug delivery company with a proprietary formulation technology called ArisCrown that has the potential to transform the injectable peptide drug market offering oral alternatives for these medications.
Arisgen is developing its own products focused on the treatment of metabolic diseases and oncology and actively seeking partners for the technology.